Microbot Medical (MBOT) Fundamentals 2026 — Revenue Analysis | SniperIQ
Microbot Medical (MBOT) is a US-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of $81M, trading at
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Microbot Medical's market cap?
Microbot Medical (MBOT) has a market capitalization of approximately $81M, trading at
What is Microbot Medical's P/E ratio?
Microbot Medical's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Microbot Medical?
Microbot Medical runs a net profit margin of -13535.2%, a gross margin of -9.5%, and an operating margin of -15278.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Does Microbot Medical pay a dividend?
Microbot Medical does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Microbot Medical financially healthy?
Microbot Medical carries a debt-to-equity ratio of 0.01x and a current ratio of 22.59x, with a market beta of 1.04. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Microbot Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Microbot Medical (MBOT) the key facts are: market cap $81M, 52-week range 1.6-4.67. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Microbot Medical's full fundamentals live
Get Microbot Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.